Old arthritis drug shows promise against aggressive breast cancer
Disease control
Completed
This study tested a daily pill called leflunomide in 17 women with metastatic triple negative breast cancer, a fast-growing type with few treatment options. The goal was to find a safe dose and see if the drug could shrink tumors or slow the disease. Leflunomide is already used f…
Phase: PHASE1, PHASE2 • Sponsor: Joseph Sparano • Aim: Disease control
Last updated May 01, 2026 15:59 UTC